Literature DB >> 11641637

Penetrating keratoplasty in infants.

R M Comer1, S M Daya, M O'Keefe.   

Abstract

PURPOSE: To analyze graft survival and visual outcome after penetrating keratoplasty in infants with congenital corneal opacity.
METHODS: We retrospectively reviewed the records of 11 patients with congenital corneal opacity who underwent penetrating keratoplasty as infants. Six patients had a diagnosis of Peter's anomaly, 1 of congenital hereditary endothelial dystrophy, 1 of posterior polymorphous dystrophy, and 2 of sclerocornea, and in the other patient, the cause of the opacity was unknown.
RESULTS: In total, 26 penetrating keratoplasties were performed on 16 eyes of 11 infants. All patients initially underwent surgery before the age of 13 months. Five patients underwent bilateral penetrating keratoplasty, and 10 of the transplants were repeat operations on eyes that had already had at least one previously failed graft. The age of the infants at the time of first penetrating keratoplasty ranged from 2 to 56 weeks (median, 13 weeks). The graft survival time for all transplants ranged from 3 to 137 months (median, 16 months). Overall first graft survival at 12 months was 61% (95% CI, 33%-81%), with 10 of 16 eyes retaining a clear corneal graft. Peter's anomaly, lensectomy, and repeat penetrating keratoplasty were factors most highly associated with poor graft survival and a low final visual acuity.
CONCLUSION: Early penetrating keratoplasty for congenital corneal opacity may prevent deprivation amblyopia. Although this procedure carries a high risk of failure, particularly in those patients with Peter's anomaly, careful case selection, optical correction, and management of postoperative amblyopia may result in a successful visual outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11641637     DOI: 10.1067/mpa.2001.117568

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  8 in total

1.  The Palisades of Vogt in Congenital Corneal Opacification (An American Ophthalmological Society Thesis).

Authors:  Ken K Nischal; Kira L Lathrop
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

2.  Boston Keratoprosthesis: expanding the boundaries.

Authors:  Mona Harissi-Dagher
Journal:  Digit J Ophthalmol       Date:  2011-11-03

Review 3.  The challenging management of pediatric corneal transplantation: an overview of surgical and clinical experiences.

Authors:  Antonio Di Zazzo; Stefano Bonini; Salvatore Crugliano; Michele Fortunato
Journal:  Jpn J Ophthalmol       Date:  2017-04-03       Impact factor: 2.447

4.  Descemet stripping automated endothelial keratoplasty in pediatric age group.

Authors:  Silvana Madi; Paolo Santorum; Massimo Busin
Journal:  Saudi J Ophthalmol       Date:  2012-05-12

5.  Indications and outcomes of pediatric keratoplasty in a tertiary eye care center: A retrospective review.

Authors:  Rosario Gulias-Cañizo; Roberto Gonzalez-Salinas; Luis Fernando Hernandez-Zimbron; Everardo Hernandez-Quintela; Valeria Sanchez-Huerta
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

6.  Genetic analysis of chromosome 20-related posterior polymorphous corneal dystrophy: genetic heterogeneity and exclusion of three candidate genes.

Authors:  S Mohsen Hosseini; Sarah Herd; Andrea L Vincent; Elise Héon
Journal:  Mol Vis       Date:  2008-01-16       Impact factor: 2.367

7.  Epithelial phenotype in total sclerocornea.

Authors:  David Hui-Kang Ma; Lung-Kung Yeh; Hung-Chi Chen; Anna Marie Chang; Yi-Ju Ho; Shirley H L Chang; Unique Yang
Journal:  Mol Vis       Date:  2014-04-11       Impact factor: 2.367

8.  Microscope Integrated Optical Coherence Tomography Guided Descemet Stripping Automated Endothelial Keratoplasty in Congenital Hereditary Endothelial Dystrophy.

Authors:  Mohamed Ibrahime Asif; Rahul Kumar Bafna; Namrata Sharma; Ananya Kaginalkar; Rajesh Sinha; Tushar Agarwal; Prafulla Kumar Maharana; Manpreet Kaur; Priya Taank; Jeewan S Titiyal
Journal:  Clin Ophthalmol       Date:  2021-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.